Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hoffmann-La Roche
Related studies linked through entity extraction aliases.
Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advanced Inoperable or Metastatic HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])
- Status
- COMPLETED
- Phase
- N/A
A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE3
Quality of Life Study in Participants With IPF Under Pirfenidone Treatment
- Status
- COMPLETED
- Phase
- N/A
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE3
Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment
- Status
- COMPLETED
- Phase
- N/A
The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience
- Status
- WITHDRAWN
- Phase
- N/A
A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Compare Bioavailability of RO7239361 After Subcutaneous Injection
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2